United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, inc. - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8) - fosinopril sodium 20 mg - fosinopril sodium tablets are indicated for the treatment of hypertension. they may be used alone or in combination with thiazide diuretics. fosinopril sodium tablets are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see dosage and administration). in using fosinopril sodium tablets, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril sodium does not have a similar risk (see warnings ). in considering use of fosinopril sodium tablets, it should be noted that in controlled trials ace inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. in addition, ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - fosinopril sodium (unii: nw2rth6t2n) (fosinoprilat - unii:s312ey6zt8) - fosinopril sodium 20 mg - fosinopril sodium tablets, usp are indicated for the treatment of hypertension. it may be used alone or in combination with thiazide diuretics. fosinopril sodium tablets, usp are indicated in the management of heart failure as adjunctive therapy when added to conventional therapy including diuretics with or without digitalis (see dosage and administration ). in using fosinopril sodium, consideration should be given to the fact that another angiotensin converting enzyme inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. available data are insufficient to show that fosinopril sodium does not have a similar risk (see warnings ). in considering use of fosinopril sodium, it should be noted that in controlled trials ace inhibitors have an effect on blood pressure that is less in black patients than in non- blacks. in addition, ace inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - fosinopril sodium,hydrochlorothiazide -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - fosinopril sodium,hydrochlorothiazide -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - fosinopril sodium,hydrochlorothiazide -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - fosinopril sodium,hydrochlorothiazide -

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - fosinopril sodium,hydrochlorothiazide -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fosinopril sodium, quantity: 20 mg - tablet, uncoated - excipient ingredients: zinc stearate; crospovidone; lactose - hypertension - treatment of mild to moderate hypertension. fosinopril is effective alone as initial therapy or in combination with other antihypertensive agents. the antihypertensive effects of fosinopril and diuretics used concomitantly are approximately additive. data have not been provided to support the use of fosinopril in severe or renovascular hypertension. heart failure - management of heart failure when added to conventional therapy, including diuretics.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fosinopril sodium, quantity: 20 mg - tablet, uncoated - excipient ingredients: zinc stearate; lactose; crospovidone - hypertension - treatment of mild to moderate hypertension. fosinopril is effective alone as initial therapy or in combination with other antihypertensive agents. the antihypertensive effects of fosinopril and diuretics used concomitantly are approximately additive. data have not been provided to support the use of fosinopril in severe or renovascular hypertension. heart failure - management of heart failure when added to conventional therapy, including diuretics.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - fosinopril sodium, quantity: 10 mg - tablet, uncoated - excipient ingredients: zinc stearate; crospovidone; lactose - hypertension - treatment of mild to moderate hypertension. fosinopril is effective alone as initial therapy or in combination with other antihypertensive agents. the antihypertensive effects of fosinopril and diuretics used concomitantly are approximately additive. data have not been provided to support the use of fosinopril in severe or renovascular hypertension. heart failure - management of heart failure when added to conventional therapy, including diuretics.